Skip to main content

Cryoablation for Monomorphic Ventricular Tachycardia

Active, not recruiting · Not applicable · NCT05675865

Conditions: Sustained VT

At a glance

Research payments reported, 2025
$1.3M
U.S. investigators named
10
Sites paid
20
Planned or actual enrollment
206

About the trial

Sponsor
Adagio Medical
Tested
cryoablation procedure (device)
Dates
Started 2023-09-11; completion 2027-03-30
Results posted
Not yet

The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)

From ClinicalTrials.gov, last updated 2026-08-07. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Adagio Medical, Inc. reported $1.3M in research payments for this study in 2025 (71 payments).

Products named: Cryoablation for Monomorphic Ventricular Tachycardia (fulcrum-Vt)

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.